Project Grant R43GM156162
Award Date
7/5/24
Completion Date
6/30/25
Dollars Obligated
$299K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
West Menlo Park, CA 94025, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $356,497 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Kinetic River Corp. on August 15, 2024. The purpose of this grant is to develop an ultrasensitive flow cytometry system capable of providing multiparametric analysis of therapeutic anti-aging extracellular vesicles (EVs). Extracellular vesicles are small, lipid-bound vesicles secreted by cells that show promise as therapeutics for a wide range...
This $500,000 National Science Foundation project grant supports research to advance the biom anufacturing of extracellular vesicles through the integration of human induced pluripotent stem cell technology, genome engineering, and membrane nanofabrication. The primary recipient is Syracuse University, with Rochester Institute of Technology serving as a sub-awardee. Under the Biological Sciences program (CFDA 47.074), the grantees will work to generate a stable human iPSC line with enhanced EV...
This federal Project Grant award of $882,000, provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to engineer hybrid extracellular vesicles (HEVs) derived from natural killer (NK) cells and combine them with liposomes containing anticancer drugs and imaging dyes. The key objectives are to: 1) engineer the NK cell-derived extracellular vesicles...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of a commercial prototype for a multi-functional Plasmonic Scattering Microscopy (PSM) instrument. The total funding amount is $295,561, awarded to Biosensing Instrument Inc., a for-profit manufacturer of advanced biomedical research technologies based in Tempe, Arizona. The PSM technology aims to enable high-throughput,...
This Project Grant award, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" program (CFDA 93.286), aims to develop machine learning-enabled characterization of extracellular vesicles (EVs) using nanoplasmonic microfluidics for ovarian cancer detection and monitoring. The $576,716.86 award to Northwestern University, granted on September 12, 2024, will support...
This $516,355.74 Project Grant from the National Cancer Institute, part of the Department of Health and Human Services, aims to develop new technologies for immunotherapy monitoring and liquid biopsy through the Cancer Research Manpower federal grant program. Specifically, the Massachusetts General Hospital will utilize the funding to create an ultra-high sensitive platform that can map single extracellular vesicles to parent cells at the single particle level and apply it to profile tumor...
This $415,830 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to develop an integrated nanoplasmonic sensing platform called "Nano-CRISPR" for longitudinal monitoring of ovarian cancer using extracellular vesicles (EVs). The key products and services to be delivered include: Incorporation of single EV capture and analysis using plasmonic nanodisk arrays, CRISPR/Cas13A sensors for lysis-free,...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $349,566 to Biosensing Instrument Inc. to develop a Spotting-Free Nano-Oscillator Array (SFNOA) technology. The SFNOA system aims to enable high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. Key innovations include the use of virion-displayed...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) is funding research to develop an enzyme-free, label-free quantitative microarray technology capable of detecting and quantifying small nucleic acid sequences, such as microRNA, at attomolar concentrations. The $432,834 award to the University of Nebraska aims to design a novel "binary probe" system and specialized opto-electrochemical...
This federal Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) provides $231,413 to The General Hospital Corporation (Massachusetts General Hospital) to develop a novel SPINEX platform for rapid, high-throughput isolation and processing of extracellular vesicles (EVs) from clinical plasma samples. The SPINEX technology leverages dual-mode chromatography and disc-based fluidics to efficiently separate EVs from lipoproteins, enabling...